Whitepaper: Cancer biomarkers for immunohistochemistry

Streamline your cancer research using this guide that groups antibodies against critical cancer biomarkers according to biomarker type or tissue type.

Accurately detecting biomarkers by IHC requires highly specific, rigorously validated antibody reagents. At CST, we adhere to the Hallmarks of Antibody Validation™ and carefully tailor how we validate our biomarker antibodies for IHC, ensuring results you can trust. This guide groups the most critical biomarkers for cancer research into seven categories to emphasise the value of studying multiple biomarker types in parallel to advance the understanding of cancer.